76 results on '"Guitart, J"'
Search Results
2. 680 Identification of environmental, demographic and lifestyle risk factors for cutaneous T cell lymphoma: A single institution case-control study
3. 1318 Racial differences in the skin microbiome of cutaneous T cell lymphoma patients
4. Aggressive cytotoxic dermal lymphomas of the earlobe: a single-institution case series
5. 522 Skin microbiome in cutaneous T-cell lymphoma is associated with phototherapy treatment response
6. 547 Cutaneous T-cell lymphoma is associated with nasal and gut dysbiosis and altered bacterial signatures
7. 859 Skin tape strip proteomics in mycosis fungoides identifies tumor associated biomarkers
8. 224 Risk factors and outcomes for sepsis in cutaneous T cell lymphoma compared to in other non-Hodgkin lymphomas
9. Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy
10. Gut dysbiosis in cutaneous T‐cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease
11. 420 Topical hypericin ointment photodynamic therapy is effective and safe in CTCL (FLASH study)
12. 282 Lifestyle and demographic risk factors in mycosis fungoides and Sezary syndrome: A single institution cohort study
13. Cutaneous T‐cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program
14. Cutaneous T Cell Lymphomas
15. Cutaneous T-Cell Lymphomas
16. MON-PO427: Functional and Nutritional Status of the Patients with Subacute Stroke at Admission and at Discharge from the Brain Injury Unit of La Pedrera Long-Stay Hospital (HLP)
17. Corrections to “Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium”
18. Gain, saturation and noise figure of a travelling wave semiconductor optical amplifier
19. 250 Evidence for race/ethnic incidence rate disparity in mycosis fungoides: A report from the NCI surveillance, epidemiology, and end results (SEER) program
20. 607 Anti-pruritic properties of remetinostat (SHAPE), a topical histone deacetylase inhibitor (HDACi); data from a randomized phase 2 study in patients with stage IA- IIA mycosis fungoides
21. Pigmented onychomatricoma: a rare mimic of subungual melanoma
22. Design and control strategies for a modular hydroKinetic smart grid
23. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
24. LB959 Hemophagocytic lymphohistiocytosis in cytotoxic cutaneous T-cell lymphoma: Delayed diagnosis of a life-threatening complication
25. Ablación percutánea mediante radiofrecuencia de tumores renales en pacientes de alto riesgo: 10 años de experiencia
26. Percutaneous radiofrequency ablation of renal tumors in high-risk patients: 10 years’ experience
27. 183 Cutaneous lymphoma international consortium (CLIC): Uniting worldwide experts to develop and validate a prognostic index model
28. Epidermal necrosis with multinucleated keratinocytes: a possible diagnostic clue for dermatitis artefacta in children
29. γδ T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous γδ T-cell lymphomas
30. On the (d,D,D,s)-digraph problem
31. An industrial process for 650V rated GaN-on-Si power devices using in-situ SiN as a gate dielectric
32. Outcome of Patients Treated with a Single-Fraction Dose of Radiation for Cutaneous T-cell Lymphoma and Mycosis Fungoides
33. XIV. T- and NK-cell lymphoproliferative disorders
34. Satisfaction and complications comparing flexible reinforced laryngeal mask airways (FRLMA) with ETT in surgery of the face in adults
35. Histopathologic and immunohistochemical findings of skin rash to HER1 and HER1/2 inhibitors during anticancer therapy.
36. Histological differentiation of skin toxicity between cetuximab, erlotinib and panitumumab (single ErbB1) and lapatinib (dual ErbB1/2) epidermal growth factor receptor inhibitors
37. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
38. Maximizing revenue in Grid markets using an economically enhanced resource manager
39. A control tool for irrigation canals with scheduled demands
40. Errata for “Explicit Analytical Charge and Capacitance Models of Undoped Double-Gate MOSFETs” [Jul 07 1718-1724]
41. Criterios de derivaci?n de la medicina primaria a la especializada del paciente demente. Criterios de ingreso hospitalario del paciente demente
42. Demencia vascular. Concepto. Manifestaciones cl?nicas. Manejo terap?utico
43. Folliculotropic Sézary syndrome: a new variant of cutaneous T-cell lymphoma
44. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma
45. Cyclin D1 Expression in Melanocytic Lesions of the Skin
46. Laminin‐5 Expression in Melanocytic Lesions of the Skin
47. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus
48. Cutaneous T-Cell Lymphoma: A Paradigm for Biological Therapies
49. ‘Eruptive syringoma’: a misnomer for a reactive eccrine gland ductal proliferation?
50. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.